ZENOCUTUZUMAB

UNII: AE72RB1W1X
Preferred Substance Name: ZENOCUTUZUMAB

1969309-56-5
IMMUNOGLOBULIN G1, BISPECIFIC, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTORS, HER2 AND HER3) (HUMANIZED CLONE MCLA-128 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED CLONE MCLA-128 LIGHT CHAIN, DIMER
MCLA128
MCLA-128
MCLA-128 (IGG1 BISPECIFIC ANTIBODY WITH ENHANCED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) ACTIVITY TARGETING HER2 AND HER3 RECEPTORS.)
ZENOCUTUZUMAB [INN]
ZENOCUTUZUMAB [USAN]
ZENOCUTUZUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ZENOCUTUZUMAB

Synonyms and Mappings

Resources

Note